Knights Of Columbus Asset Advisors LLC Karuna Therapeutics, Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

  • $1.48 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024
BUY
$161.01 - $317.85 $175,339 - $346,138
1,089 Added 94.53%
2,241 $709,000
Q3 2023

Nov 01, 2023
BUY
$164.66 - $218.08 $10,208 - $13,520
62 Added 5.69%
1,152 $194,000
Q2 2023

Jul 31, 2023
BUY
$176.32 - $240.22 $192,188 - $261,839
1,090 New
1,090 $236,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email